PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 59 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

26 October 2024

  1. (diff | hist) m 16:02 Fasting insulin 2,042 +380 LipidLedgerLou (talk | contribs) clarify that the units differ between the two cited papers [rollback]
  2. (diff | hist) 15:31 Dipeptidyl peptidase-4 4,012 +717 StabilityStig (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 07:00 Bacterial endotoxin test 2,929 ±0 Chromatokid (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  4. (diff | hist) m b 06:06 Injection site rotation 2,929 +29 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  5. (diff | hist) 06:02 Research use only 3,726 ±0 PharmDrafts (talk | contribs) add the date the shortage listing ended [rollback]
  6. (diff | hist) 03:35 SURPASS trial programme 2,611 ±0 TriumphThad (talk | contribs) give the absolute risk difference alongside the relative one [rollback]

25 October 2024

  1. (diff | hist) N 21:38 Growth hormone secretagogue 1,239 +1,239 SPPS_Sorrel (talk | contribs) new article: research peptide, expansion welcome
  2. (diff | hist) 18:51 Peptide content 3,491 +537 PeakShapePol (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  3. (diff | hist) 13:00 Amylin receptor agonist 2,228 +627 RedirectRini (talk | contribs) expand §Analytical notes [rollback]
  4. (diff | hist) 10:41 GL Biochem (Shanghai) 7,376 +474 EndotoxinEd (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  5. (diff | hist) 08:18 Placebo-adjusted effect 2,157 ±0 GramsNotUnitsGil (talk | contribs) add the randomisation ratio [rollback]
  6. (diff | hist) m 02:17 Analytical method validation 2,979 ±0 Peptide_Pete (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]

24 October 2024

  1. (diff | hist) 22:01 Beyond-use date 4,264 +1,039 EscalationEira (talk | contribs) fix the arithmetic in the worked reconstitution example [rollback]
  2. (diff | hist) 21:12 Drug master file 1,551 ±0 TrialsTabitha (talk | contribs) expand §What a DMF claim establishes [rollback]
  3. (diff | hist) 20:17 SURMOUNT trial programme 2,668 +101 StyleSheetSybil (talk | contribs) expand §Scope of the evidence [rollback]
  4. (diff | hist) 19:43 Medutest 2,738 +30 UnderfillUna (talk | contribs) British spelling per PP:MOS [rollback]
  5. (diff | hist) m 15:53 Reconstitution of lyophilised peptides 3,118 +28 EscalationEira (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  6. (diff | hist) 15:08 Repackaging 2,063 ±0 LurkerLevi (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  7. (diff | hist) m 14:13 Prescribing information 2,473 +270 SarcopeniaSefa (talk | contribs) rm the projection; nothing cited supports it [rollback]
  8. (diff | hist) 13:07 Residual solvent 2,880 ±0 TFA_Counterion (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  9. (diff | hist) m 08:46 LEADER trial 2,357 +170 PreregPriya (talk | contribs) add category for the trial programme [rollback]
  10. (diff | hist) m 08:45 Loss on drying 2,569 +295 LOD_Lorcan (talk | contribs) add the note on co-elution and what it hides [rollback]
  11. (diff | hist) m b 01:48 Lot traceability 2,794 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) m 01:14 Blind sampling 3,474 +365 EndotoxinEd (talk | contribs) split §What a report shows from §What it does not [rollback]
  13. (diff | hist) 01:10 Bachem Holding (Suzhou) 2,097 ±0 BlindSampleBrid (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]

23 October 2024

  1. (diff | hist) 21:35 Insulin syringe unit conversion 1,462 +160 ScopeSeverin (talk | contribs) rm the administration advice; the tool computes, it does not instruct [rollback]
  2. (diff | hist) m 20:19 Weight regain after discontinuation 2,822 +30 ToleranceTove (talk | contribs) convert the adverse-event list to a table with both arms [rollback]
  3. (diff | hist) m 18:13 Intention-to-treat analysis 2,691 ±0 ForestPlotFinn (talk | contribs) expand §Why analysing as treated fails [rollback]
  4. (diff | hist) 18:04 Batch number 2,494 ±0 VerifyFirstVida (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 15:50 Preparative HPLC purification 3,361 +665 SPPS_Sorrel (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]
  6. (diff | hist) N 13:39 Deamidation 1,364 +1,364 AAA_Analyst (talk | contribs) create article — method stub
  7. (diff | hist) m 11:12 STEP trial programme 3,324 ±0 SemaglutideSasha (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  8. (diff | hist) 10:04 Talk:Blind sampling 1,033 +90 BlindSampleBrid (talk | contribs) /* Is "almost no" defensible without a count? */ reply
  9. (diff | hist) 06:54 HOMA-IR 1,827 ±0 Chromatokid (talk | contribs) expand §Behaviour under weight loss and incretin therapy [rollback]
  10. (diff | hist) 05:21 Oral semaglutide 2,537 ±0 TimelineTiernan (talk | contribs) British spelling per PP:MOS [rollback]
  11. (diff | hist) 05:15 Peptide aggregation 2,241 ±0 RedirectRini (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  12. (diff | hist) m 03:36 CagriSema 2,223 +562 LiraLotte (talk | contribs) expand §Reported findings [rollback]
  13. (diff | hist) m b 02:34 Sterility testing 2,226 +318 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  14. (diff | hist) m 00:15 Cold-chain freight 1,900 ±0 AppendixAlva (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]

22 October 2024

  1. (diff | hist) m 20:33 Arcuate nucleus 2,700 +353 BetaCellBoyd (talk | contribs) expand §Access to circulating signals [rollback]
  2. (diff | hist) 18:58 Receptor bias 2,355 +250 CommaCarys (talk | contribs) fix the anchor on an internal link [rollback]
  3. (diff | hist) 18:32 Mass spectrometry 3,840 ±0 TechnicianTeal (talk | contribs) add the detection wavelength [rollback]
  4. (diff | hist) 18:20 Incretin effect 4,860 +57 GsCouplingGil (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  5. (diff | hist) m 13:43 ChinaPeptides 1,725 +38 LotTraceLuka (talk | contribs) expand §Product range [rollback]
  6. (diff | hist) m 12:01 Dose escalation schedule 1,918 ±0 BUD_Bertram (talk | contribs) add the diluent volume the example assumes [rollback]
  7. (diff | hist) N 11:48 Baseline laboratory panel 1,276 +1,276 A1c_Alder (talk | contribs) create article — laboratory stub
  8. (diff | hist) 09:41 Certificate of analysis 4,248 +389 PurityClaimPia (talk | contribs) ce per PP:MOS [rollback]
  9. (diff | hist) N 09:00 Drug master file 1,551 +1,551 MissedDoseMik (talk | contribs) new article: drug regulation, expansion welcome
  10. (diff | hist) 08:53 GLP-1 receptor 4,864 ±0 HalfLifeHavel (talk | contribs) alphabetise the see-also list [rollback]
  11. (diff | hist) 08:29 Talk:Blind sampling 822 +136 ChainCustodyChad (talk | contribs) /* Is "almost no" defensible without a count? */ reply
  12. (diff | hist) m 07:21 Good manufacturing practice 2,472 +33 MTC_Marisol (talk | contribs) move a stray full stop inside the reference [rollback]
  13. (diff | hist) m 07:17 Limit of detection 2,589 ±0 NewLabNell (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  14. (diff | hist) 05:12 Peptide supply chain 2,638 +1,260 CDMO_Caradoc (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  15. (diff | hist) 05:07 Guangzhou JEEP Biotechnology 5,366 ±0 BlindSampleBrid (talk | contribs) add the catalogue size and label it self-reported [rollback]
  16. (diff | hist) m b 04:52 Wuhan Wansheng Biotechnology 6,273 +201 CiteBot (talk | contribs) bot: sort category members [rollback]
  17. (diff | hist) m b 04:08 International nonproprietary name 1,833 +727 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  18. (diff | hist) 01:19 TRIUMPH trial programme 2,480 +524 FiveOhThreeA (talk | contribs) add the confidence interval to the point estimate [rollback]

21 October 2024

  1. (diff | hist) 20:17 ISO 9001 2,449 +32 Compounding_Cate (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  2. (diff | hist) 18:19 Qingdao Sigma Chemical 4,472 +231 AnalyticalAnnie (talk | contribs) expand §External links [rollback]
  3. (diff | hist) 13:47 Talk:Blind sampling 611 +225 TallySheetTad (talk | contribs) /* Is "almost no" defensible without a count? */ reply
  4. (diff | hist) m b 12:41 PeptideMeter 2,760 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 09:12 Talk:Blind sampling 400 +169 BlindSampleBrid (talk | contribs) /* Is "almost no" defensible without a count? */ new section
  6. (diff | hist) 06:22 WuXi TIDES 5,916 +1,329 eGFR_Esme (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  7. (diff | hist) 05:29 Sterile water for injection 2,419 ±0 UnitAuditUwe (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  8. (diff | hist) 00:26 GLP-1 receptor agonist 6,307 +187 LOD_Lorcan (talk | contribs) expand §Molecular strategies for half-life extension [rollback]

20 October 2024

  1. (diff | hist) 22:49 Trifluoroacetate counterion 2,370 ±0 AmylinAmos (talk | contribs) ce [rollback]
  2. (diff | hist) m 21:36 Chinese Peptide Company 4,511 +192 BlindSampleBrid (talk | contribs) state the city and province of the registered address [rollback]
  3. (diff | hist) 16:58 Custom peptide synthesis 2,407 +268 PrepHPLC_Pia (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) m 16:23 Amylin 3,204 +639 IcodecIndra (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  5. (diff | hist) m 16:16 Electrospray ionisation 2,185 +206 KarlFischerKit (talk | contribs) add the detection wavelength [rollback]
  6. (diff | hist) m 11:19 Nantong Guangyuan Chemical 5,871 +159 TallySheetTad (talk | contribs) expand §Ordering and availability [rollback]
  7. (diff | hist) m 08:42 Exenatide 1,991 +715 Retention_Time_Rae (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  8. (diff | hist) 04:22 Chain of custody 2,933 +260 VerifyVesna (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  9. (diff | hist) 00:57 Test report forgery 1,998 +676 VerifyFirstVida (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  10. (diff | hist) 00:12 Insulin secretion 3,940 +134 Chromatokid (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]

19 October 2024

  1. (diff | hist) 10:37 Cold chain 11,453 +163 PeakShapePol (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  2. (diff | hist) m b 09:43 Retatrutide 3,907 +425 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 05:07 Reference standard 2,872 ±0 DeadSpaceDot (talk | contribs) expand §Use in identification [rollback]
  4. (diff | hist) m 04:11 USP General Chapter 85 2,086 +810 IsocraticIla (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  5. (diff | hist) 02:40 C-peptide 2,537 +31 ApoB_Aurelio (talk | contribs) add the units and the conversion factor to SI [rollback]
  6. (diff | hist) 01:50 Lixisenatide 1,771 ±0 AnalyticalAnnie (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]

18 October 2024

  1. (diff | hist) N 23:41 CagriSema 1,661 +1,661 MergeMorwenna (talk | contribs) create article — compound stub
  2. (diff | hist) m 22:14 Lyophilisation 7,435 ±0 CoI_Corin (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  3. (diff | hist) 18:12 Peptide aggregation 2,241 ±0 LeaderLoic (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  4. (diff | hist) 17:16 FLOW trial 1,950 ±0 TirzTaxonomist (talk | contribs) split the results table so the two doses are separate rows [rollback]
  5. (diff | hist) 11:43 Subcutaneous injection 2,986 +28 Chromatokid (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  6. (diff | hist) 10:24 Talk:Hunan Aslsen Technology 1,033 +106 VerifyVesna (talk | contribs) /* "Verified by" is not a test result */ reply
  7. (diff | hist) 09:36 Aspiration risk under anaesthesia 2,259 +1,029 MTC_Marisol (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  8. (diff | hist) N 09:00 Insulin syringe unit conversion 1,302 +1,302 DiffWatchDov (talk | contribs) new article: reference tool, expansion welcome
  9. (diff | hist) 05:28 Liraglutide 3,239 ±0 ColdChainCleo (talk | contribs) add short description [rollback]
  10. (diff | hist) 03:14 Area percent purity 3,346 +369 ResolutionRoo (talk | contribs) clarify that area percent is not mass percent [rollback]
  11. (diff | hist) 03:10 Cagrilintide 2,406 ±0 SchematicScout (talk | contribs) add the peptide length to the infobox [rollback]

17 October 2024

  1. (diff | hist) 22:53 Number needed to treat 1,750 +628 TriumphThad (talk | contribs) expand §Number needed to harm [rollback]
  2. (diff | hist) 18:18 Janoshik Analytical 2,971 ±0 BlankVialBo (talk | contribs) correct the description of the sampling procedure [rollback]
  3. (diff | hist) 17:27 Amylin receptor agonist 1,601 ±0 PrimarySrcPatia (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  4. (diff | hist) 10:13 Missed dose 2,029 +597 Chromatokid (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  5. (diff | hist) m 05:04 Tirzepatide 4,843 +137 TelehealthTruus (talk | contribs) add the receptor targets to the lead sentence [rollback]
  6. (diff | hist) 03:25 Beyond-use date 3,225 +1,009 BUD_Bertram (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  7. (diff | hist) m b 02:40 Bachem Holding (Suzhou) 2,097 +411 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) N 00:41 Beyond-use date 2,216 +2,216 UnitAuditUwe (talk | contribs) new article: dosing and handling, expansion welcome